NexPhase Capital Exits Investment in OmniSYS Through Sale to XIFIN

New York, NY-December 23, 2021

NexPhase Capital, LP (“NexPhase”), a thematic and operationally focused private equity firm, announced today the sale of OmniSYS, a leading provider of technology solutions for the retail pharmacy industry, to XIFIN, a healthcare IT company focused on improving the economics and delivery of care. Together, XIFIN and OmniSYS will support retail pharmacies as they transition to a clinical services business model, drive closer relationships between pharmacies and diagnostic providers, and bring together complementary clinical and financial information via integrated cloud-based technologies.

“In close partnership with NexPhase, OmniSYS reached new heights to become a dominant operator in the pharmacy services space including becoming one of the leading processors of pharmacy administered immunizations” said John King, CEO of OmniSYS. “We are grateful for our partnership with the NexPhase team, whose consistent support and strategic guidance have been instrumental to the exceptional growth of this enterprise.”  

Serving more than 30,000 pharmacies, including four of the top five national chains, OmniSYS helps retail pharmacies transition into their expanding role as providers of medical care for the communities they serve. OmniSYS technology digitizes and optimizes many facets of their business, including improving medical claims processing, clinical workflow and patient engagement. The company is one of the leading retail pharmacy revenue cycle management platforms, offering the industry’s only cloud-based, clinically integrated revenue cycle platform supporting medical billing in the pharmacy setting. In addition to serving over half the pharmacies in the country, OmniSYS also works with several major pharmaceutical companies to improve population health by increasing vaccination rates of important vaccines.

“OmniSYS has created an exceptional pharmacy services platform through numerous successful investments in people, processes, infrastructure, and acquisitions. It has been a pleasure partnering with John and his team to advance our shared vision for the business and we wish them continued success under XIFIN’s ownership,” said Andy Kieffer, Partner at NexPhase.

Triple Tree and Lincoln International acted as financial advisors to NexPhase and OmniSYS on the transaction while McDermott Will & Emory served as legal advisor.​​​​​​

About OmniSYS 

OmniSYS is a technology company with 25+ years of experience working with pharmacies, payers, providers and pharmaceutical manufacturers. The company leverages this unique market insight along with its pharmacy workflow expertise to deliver valuable solutions that help pharmacies thrive in the changing pharmacy landscape. OmniSYS solutions help pharmacies engage patients, grow clinical services and improve financial performance. The company serves over 30,000 pharmacies, connects to hundreds of payers and touches millions of patient lives. Visit to learn more. ​​​​​​​

About NexPhase Capital

NexPhase Capital is a thematic and operationally focused private equity firm that invests in lower middle market growth-oriented companies within three distinct sectors: consumer, healthcare and software. The firm partners with founders whose companies have reached a growth inflection point and are seeking a value-added partner to help navigate the company’s “next phase.” NexPhase Capital targets control equity investments between $25 million and $150 million. The NexPhase healthcare team focuses primarily on investing in service-oriented companies. Recent healthcare investments include Calcium, a marketing services provider to the biopharma space, and Clearway Pain Solutions, an interventional pain management provider. Visit to learn more.​​​​​​​